This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Regularly reassessing your budget is essential for financial success. Learn the benefits of keeping your budget aligned with your goals.
26,572 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Rivian is targeting a major production shift with the R2 lineup. This guide weighs the bull and bear cases for rivian...
Fraudsters increasingly impersonate seniors to access bank funds. Learn how the posed elderly account holder scam unf...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
When KD shares surged mid-morning, traders asked if the move reflected real earnings momentum or relief from a scare....
As DNOW readies its 2025 earnings narrative, investors should focus on backlog, free cash flow, and guidance. This gu...
GameStop is weighing a bold move: acquiring eBay. This article breaks down whether does Gamestop's proposed acquisiti...
When Berkshire Hathaway named Greg Abel to lead investments, the portfolio made a surprising pivot. This article brea...
Two AI stock contenders show different paths for growth and profits. This guide explains how to read quarterly revenu...
Rocket Lab’s stock faced a sharp pullback before rebounding in March. This article breaks down what caused the drop, ...
As the U.S. ramps up nuclear capacity, one stock could benefit from policy shifts, domestic fuel security, and growin...
Could mercadolibre stock headed $2,800? be more than a headline. This deep dive examines growth drivers, risks, and h...